4. Merck

Total Ad Spend: $285.5 million
Television: $133.7 million
Magazine: $87.8 million
Other: $64 million

After resolving the manufacturing and supply problems that constricted supplies of Zostavax for several years, Merck ($MRK) decided on a disease-awareness campaign to herald its revival in the market. The campaign must have worked, because Zostavax was one of the best-selling vaccines last year.

In the spotlight

Shingles awareness, $46.7 million
Nasonex, $46.3 million
Zostavax, $46 million



Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.